Ghost Tree Capital's AUM, Returns and Holdings
David Kim's Ghost Tree Capital is a health-care oriented hedge fund with a headquarter in New York.
Founded in April 2013, Ghost Tree Capital is a New York-based hedge fund manager predominantly owned by David Kim. Specializing in a long/short equity strategy centered on the healthcare industry, the firm's goal is to achieve steady absolute returns. Ghost Tree Capital identifies undervalued opportunities in healthcare through rigorous fundamental analysis, emphasizing investments that are typically undervalued or overlooked. The firm maintains a low net exposure and constructs a highly diversified, low-volatility portfolio to mitigate risk and optimize performance.
David Kim is the Founder and Chief Investment Officer of Ghost Tree Capital. He leverages extensive expertise gained from key positions at Diamondback Capital and Citadel Investment Group. David Kim earned his Doctor of Medicine (M.D) from The Johns Hopkins University School of Medicine, graduating between 1996 and 2001.
Ghost Tree Capital manages discretionary assets totaling $359,964,950 as of March 2024, according to their Form ADV. Their latest 13F filing for Q1 2024 disclosed managing $361,294,423 in 13F securities, with a significant concentration in their top 10 holdings amounting to 40.07% of their portfolio. Notably, their largest holding is 250,000 shares of the SPDR Biotech ETF.
